1. [Home](https://www.g2.com/)
2. ...
3. [Emerging AI Software](https://www.g2.com/categories/emerging-ai-software)
4. [PhaseV Trial Optimizer Discussions](https://www.g2.com/products/phasev-trial-optimizer/discuss)

[
 ![Product Avatar Image](https://images.g2crowd.com/uploads/product/image/large_detail/large_detail_632ff45cf287e0121ec1dcd46a4edb8c/phasev-trial-optimizer.jpg "Product Avatar Image")
](/products/phasev-trial-optimizer/reviews)

[

PhaseV Trial Optimizer

](/products/phasev-trial-optimizer/reviews)

0 ratings

PhaseV Trial Optimizer is an AI/ML-powered decision support platform designed to enhance the design and execution of Phase 1–3 clinical trials. By integrating multiple data sources, including sponsor-provided and external datasets, the platform enables biopharmaceutical companies and Contract Research Organizations (CROs) to navigate complex trade-offs such as cost, power, duration, probability of success, and adaptability. To date, Trial Optimizer has helped sponsors reduce patient recruitment and trial duration by up to 40%, cut development costs by as much as 50%, and increase the probability of success by over 30%. Key Features and Functionality: - Rapid Simulation Engine: Conducts millions of simulations within minutes to optimize trial designs, including fixed, adaptive, and Bayesian methodologies. - Causal-to-Design Integration: Utilizes insights from previous trials and real-world data to refine inclusion/exclusion criteria and inform development considerations. - Placebo Response Estimation: Models average placebo response rates by leveraging relevant study data and real-world evidence. - Multi-Stakeholder Collaboration: Designed for use across clinical operations, biostatistics, clinical development, and data science teams to promote joint decision-making. Primary Value and Problem Solved: PhaseV Trial Optimizer addresses the high failure rates and escalating costs associated with clinical trials by providing a data-driven, AI-enhanced platform that streamlines trial design and execution. By enabling rapid simulation and optimization of trial parameters, it reduces patient recruitment needs, shortens trial durations, and increases the likelihood of success, ultimately accelerating the delivery of new therapies to patients.

Show More

When users leave PhaseV Trial Optimizer reviews, G2 also collects common questions about the day-to-day use of PhaseV Trial Optimizer. These questions are then answered by our community of 850k professionals. Submit your question below and join in on the G2 Discussion.

* * *

### 0.0

Nps Score

### All PhaseV Trial Optimizer Discussions

Search

Most CommentedMost HelpfulCommon QuestionsNewest

All DiscussionsDiscussions with CommentsCommon QuestionsDiscussions without Comments

FilterFilter

Filter byExpand/Collapse 

Sort by

Most Commented

Most Helpful

Common Questions

Newest

Filter by

All Discussions

Discussions with Comments

Common Questions

Discussions without Comments

Sorry...

There are no questions about PhaseV Trial Optimizer yet.

## Start a New Software Discussion

Have a software question?

Get answers from real users and experts

[Start A Discussion](/products/phasev-trial-optimizer/discussions/new)

* * *

 ![Product Avatar Image](https://images.g2crowd.com/uploads/product/image/thumb_square/thumb_square_632ff45cf287e0121ec1dcd46a4edb8c/phasev-trial-optimizer.jpg "Product Avatar Image")

### Have you used PhaseV Trial Optimizer before?

Answer a few questions to help the PhaseV Trial Optimizer community

[
Yes
](javascript:void(0))[
Yes
](https://www.g2.com/login?context=product_review&return_to=https%3A%2F%2Fwww.g2.com%2Fproducts%2Fphasev-trial-optimizer%2Fdiscuss%3Fsmall_ask%3Dphasev-trial-optimizer)
No